Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

NCT00572897 is registered in ClinicalTrials.gov with John Mascarenhas as lead sponsor.

NCT NCT00572897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00572897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
Lead sponsor
John Mascarenhas
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
June 15, 2015
Enrollment
66 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis